Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. AbbVie, Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Pfizer Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Novartis AG
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Merck & Co., Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Teva Pharmaceutical Industries Ltd.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Lupin Pharmaceuticals, Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Viatris, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Melinta Therapeutics LLC
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Cipla, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Shionogi & Co., Ltd.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. KYORIN Pharmaceutical Co., Ltd.
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. GSK plc
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives
8.3.16. Nabriva Therapeutics PLC
8.3.16.1. Company overview
8.3.16.2. Financial performance
8.3.16.3. Product benchmarking
8.3.16.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America Antibiotics market, by region, 2018-2030 (USD Million)
Table 3 North America Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 4 North America Antibiotics market, by type, 2018-2030 (USD Million)
Table 5 North America Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 6 U.S. Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 7 U.S. Antibiotics market, by type, 2018-2030 (USD Million)
Table 8 U.S. Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 9 Canada Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 10 Canada Antibiotics market, by type, 2018-2030 (USD Million)
Table 11 Canada Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 12 Europe Antibiotics market, by region, 2018-2030 (USD Million)
Table 13 Europe Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 14 Europe Antibiotics market, by type, 2018-2030 (USD Million)
Table 15 Europe Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 16 Germany Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 17 Germany Antibiotics market, by type, 2018-2030 (USD Million)
Table 18 Germany Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 19 UK Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 20 UK Antibiotics market, by type, 2018-2030 (USD Million)
Table 21 UK Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 22 France Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 23 France Antibiotics market, by type, 2018-2030 (USD Million)
Table 24 France Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 25 Italy Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 26 Italy Antibiotics market, by type, 2018-2030 (USD Million)
Table 27 Italy Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 28 Spain Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 29 Spain Antibiotics market, by type, 2018-2030 (USD Million)
Table 30 Spain Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 31 Denmark Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 32 Denmark Antibiotics market, by type, 2018-2030 (USD Million)
Table 33 Denmark Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 34 Sweden Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 35 Sweden Antibiotics market, by type, 2018-2030 (USD Million)
Table 36 Sweden Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 37 Norway Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 38 Norway Antibiotics market, by type, 2018-2030 (USD Million)
Table 39 Norway Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 40 Asia-Pacific Antibiotics market, by region, 2018-2030 (USD Million)
Table 41 Asia-Pacific Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 42 Asia-Pacific Antibiotics market, by type, 2018-2030 (USD Million)
Table 43 Asia-Pacific Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 44 China Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 45 China Antibiotics market, by type, 2018-2030 (USD Million)
Table 46 China Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 47 Japan Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 48 Japan Antibiotics market, by type, 2018-2030 (USD Million)
Table 49 Japan Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 50 India Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 51 India Antibiotics market, by type, 2018-2030 (USD Million)
Table 52 India Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 53 South Korea Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 54 South Korea Antibiotics market, by type, 2018-2030 (USD Million)
Table 55 South Korea Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 56 Australia Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 57 Australia Antibiotics market, by type, 2018-2030 (USD Million)
Table 58 Australia Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 59 Thailand Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 60 Thailand Antibiotics market, by type, 2018-2030 (USD Million)
Table 61 Thailand Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 62 Latin America Antibiotics market, by region, 2018-2030 (USD Million)
Table 63 Latin America Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 64 Latin America Antibiotics market, by type, 2018-2030 (USD Million)
Table 65 Latin America Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 66 Brazil Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 67 Brazil Antibiotics market, by type, 2018-2030 (USD Million)
Table 68 Brazil Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 69 Mexico Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 70 Mexico Antibiotics market, by type, 2018-2030 (USD Million)
Table 71 Mexico Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 72 Argentina Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 73 Argentina Antibiotics market, by type, 2018-2030 (USD Million)
Table 74 Argentina Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 75 MEA Antibiotics market, by region, 2018-2030 (USD Million)
Table 76 MEA Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 77 MEA Antibiotics market, by type, 2018-2030 (USD Million)
Table 78 MEA Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 79 South Africa Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 80 South Africa Antibiotics market, by type, 2018-2030 (USD Million)
Table 81 South Africa Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 82 Saudi Arabia Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 83 Saudi Arabia Antibiotics market, by type, 2018-2030 (USD Million)
Table 84 Saudi Arabia Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 85 UAE Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 86 UAE Antibiotics market, by type, 2018-2030 (USD Million)
Table 87 UAE Antibiotics market, by action mechanism, 2018-2030 (USD Million)
Table 88 Kuwait Antibiotics market, by drug class, 2018-2030 (USD Million)
Table 89 Kuwait Antibiotics market, by type, 2018-2030 (USD Million)
Table 90 Kuwait Antibiotics market, by action mechanism, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Antibiotics market: market outlook
Figure 14 Antibiotics competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Antibiotics market driver impact
Figure 20 Antibiotics market restraint impact
Figure 21 Antibiotics market strategic initiatives analysis
Figure 22 Antibiotics market: Drug Class movement analysis
Figure 23 Antibiotics market: Drug Class outlook and key takeaways
Figure 24 Cephalosporin market estimates and forecast, 2018-2030
Figure 25 Penicillin market estimates and forecast, 2018-2030
Figure 26 Fluoroquinolone market estimates and forecast, 2018-2030
Figure 27 Macrolides market estimates and forecast, 2018-2030
Figure 28 Carbapenems market estimates and forecast, 2018-2030
Figure 29 Aminoglycosides market estimates and forecast, 2018-2030
Figure 30 Sulfonamides market estimates and forecast, 2018-2030
Figure 31 7-ACA market estimates and forecast, 2018-2030
Figure 32 Others market estimates and forecast, 2018-2030
Figure 33 Antibiotics Market: Type movement Analysis
Figure 34 Antibiotics market: Type outlook and key takeaways
Figure 35 Branded Antibiotics market estimates and forecasts, 2018-2030
Figure 36 Generic Antibiotics market estimates and forecasts,2018-2030
Figure 37 Antibiotics market: Action Mechanism movement analysis
Figure 38 Antibiotics market: Action Mechanism outlook and key takeaways
Figure 39 Cell Wall Synthesis Inhibitors market estimates and forecasts, 2018-2030
Figure 40 Protein Synthesis Inhibitors market estimates and forecasts,2018-2030
Figure 41 DNA Synthesis Inhibitors market estimates and forecasts,2018-2030
Figure 42 RNA Synthesis Inhibitors market estimates and forecasts, 2018-2030
Figure 43 Mycolic Acid Inhibitors market estimates and forecasts,2018-2030
Figure 44 Others market estimates and forecasts, 2018-2030
Figure 45 Global Antibiotics market: Regional movement analysis
Figure 46 Global Antibiotics market: Regional outlook and key takeaways
Figure 47 Global Antibiotics market share and leading players
Figure 48 North America market share and leading players
Figure 49 Europe market share and leading players
Figure 50 Asia-Pacific market share and leading players
Figure 51 Latin America market share and leading players
Figure 52 Middle East & Africa market share and leading players
Figure 53 North America: SWOT
Figure 54 Europe SWOT
Figure 55 Asia-Pacific SWOT
Figure 56 Latin America SWOT
Figure 57 MEA SWOT
Figure 58 North America, by country
Figure 59 North America
Figure 60 North America market estimates and forecasts, 2018-2030
Figure 61 U.S.
Figure 62 U.S. market estimates and forecasts, 2018-2030
Figure 63 Canada
Figure 64 Canada market estimates and forecasts, 2018-2030
Figure 65 Europe
Figure 66 Europe market estimates and forecasts, 2018-2030
Figure 67 UK
Figure 68 UK market estimates and forecasts, 2018-2030
Figure 69 Germany
Figure 70 Germany market estimates and forecasts, 2018-2030
Figure 71 France
Figure 72 France market estimates and forecasts, 2018-2030
Figure 73 Italy
Figure 74 Italy market estimates and forecasts, 2018-2030
Figure 75 Spain
Figure 76 Spain market estimates and forecasts, 2018-2030
Figure 77 Denmark
Figure 78 Denmark market estimates and forecasts, 2018-2030
Figure 79 Sweden
Figure 80 Sweden market estimates and forecasts, 2018-2030
Figure 81 Norway
Figure 82 Norway market estimates and forecasts, 2018-2030
Figure 83 Asia-Pacific
Figure 84 Asia-Pacific market estimates and forecasts, 2018-2030
Figure 85 China
Figure 86 China market estimates and forecasts, 2018-2030
Figure 87 Japan
Figure 88 Japan market estimates and forecasts, 2018-2030
Figure 89 India
Figure 90 India market estimates and forecasts, 2018-2030
Figure 91 Thailand
Figure 92 Thailand market estimates and forecasts, 2018-2030
Figure 93 South Korea
Figure 94 South Korea market estimates and forecasts, 2018-2030
Figure 95 Australia
Figure 96 Australia market estimates and forecasts, 2018-2030
Figure 97 Latin America
Figure 98 Latin America market estimates and forecasts, 2018-2030
Figure 99 Brazil
Figure 100 Brazil market estimates and forecasts, 2018-2030
Figure 101 Mexico
Figure 102 Mexico market estimates and forecasts, 2018-2030
Figure 103 Argentina
Figure 104 Argentina market estimates and forecasts, 2018-2030
Figure 105 Middle East and Africa
Figure 106 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 107 South Africa
Figure 108 South Africa market estimates and forecasts, 2018-2030
Figure 109 Saudi Arabia
Figure 110 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 111 UAE
Figure 112 UAE market estimates and forecasts, 2018-2030
Figure 113 Kuwait
Figure 114 Kuwait market estimates and forecasts, 2018-2030
Figure 115 Market share of key market players- Antibiotics market
